Serum creatinine concentration, the classical biomarker of chronic kidney disease (CKD) in
cats, has important limitations that decrease its value as a biomarker of early CKD. Recently …

Current conventional tests of kidney damage and function in blood (serum creatinine and
urea nitrogen) and urine (urine protein creatinine ratio and urine specific gravity) are widely …

Background Symmetric dimethylarginine (SDMA) has been shown to be an accurate and
precise biomarker for calculating estimated glomerular filtration rate (GFR) in humans, as …

Practical relevance: Chronic kidney disease (CKD) is one of the most commonly diagnosed
diseases in older cats. In most cats, CKD is also a progressive disease and can be …

Practical relevance: Chronic kidney disease (CKD) is one of the most frequently
encountered disorders in cats, having increased in prevalence in recent decades. Although …

Background: Chronic kidney disease (CKD) is associated with morbidity and mortality in
dogs. Plasma fibroblast growth factor‐23 (FGF‐23) concentration is an independent …

Background Fibroblast growth factor‐23 (FGF‐23) and parathyroid hormone (PTH) are
commonly increased in cats with azotemic chronic kidney disease (CKD). Both are …

Background Fibroblast growth factor (FGF‐23) has an important role in phosphate
regulation. Its clinical relevance in cats with CKD has not been explored previously …

Background Advanced machine learning methods combined with large sets of health
screening data provide opportunities for diagnostic value in human and veterinary medicine …

Background Dietary protein and phosphorus (P) restriction is the mainstay for nutritional
management of chronic kidney disease (CKD). However, adequate restriction levels for cats …